SCHEMBL196886

SCHEMBL196886

Cc1nc2ccc(Cl)cn2c1-c1csc(C2(c3ccc(C(=O)NO)cc3)CCOCC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.39
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3R1 P27986 1/20 0.37
MAP3K14 Q99558 1/20 0.37
AKT1 P31749 1/20 0.35
AKT2 P31751 1/20 0.35
HDAC1 Q13547 4/20 0.35
GABRD O14764 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRA4 P48169 2/20 0.35
HDAC7 Q8WUI4 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
KMT2A Q03164 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3351547 0.94 ALDH1A1 (0.41) KCNH2ALDH1A1POLBGAAPIK3CD
SCHEMBL3350568 0.92 ALDH1A1 (0.39) KCNH2ALDH1A1POLBGAAPIK3CD
SCHEMBL197802 0.91 HDAC1 (0.39) KCNH2GAAAKT1AKT2HDAC1
SCHEMBL197185 0.89 F2RL3 (0.39) KCNH2ALDH1A1AKT1AKT2KMT2A
SCHEMBL199623 0.89 KCNH2 (0.37) KCNH2AKT1AKT2HDAC1GABRD
SCHEMBL196851 0.88 HDAC1 (0.45) KCNH2PIK3CDPIK3R1MAP3K14HDAC1
SCHEMBL197443 0.86 CDK2 (0.44) KCNH2ALDH1A1POLBGAAHDAC1
SCHEMBL197529 0.86 MKNK1 (0.40) KCNH2ALDH1A1GAAAKT1AKT2
SCHEMBL197808 0.85 AKT1 (0.45) KCNH2ALDH1A1GAAAKT1AKT2
SCHEMBL198898 0.85 F2RL3 (0.37) KCNH2ALDH1A1AKT1AKT2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088771-B2 Cycloalkylidene and heterocycloalkylidene inhibitor compounds GILEAD SCIENCES, INC. (US) 2012-01-03 US claimed
US-20100022543-A1 CYCLOALKYLIDENE AND HETEROCYCLOALKYLIDENE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. 2010-01-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022543-A1 CYCLOALKYLIDENE AND HETEROCYCLOALKYLIDENE INHIBITOR COMPOUNDS HDAC1, HDAC11, HDAC2 KCNH2 4061/4885ALDH1A1 957/4885POLB 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.